SMA Newsroom

Back to Index
AdvocacyTreatmentsNov 15, 2024

Access to spinal muscular atrophy (SMA) treatment in Denmark: a success story of how persistence can win in the end.

Denmark has achieved a major milestone in SMA advocacy!

On 28 August 2024, after years of tireless efforts, the country secured access to SMA treatment for much of the community, including adults.

TreatmentsSep 4, 2024

Community update from Biogen

We are happy to share the latest Community Statement issued by Biogen about the Phase 2/3 DEVOTE study evaluating the safety and efficacy of a higher dose regimen of nusinersen for the treatment of spinal muscular atrophy (SMA).